Skip to Main Content

Advertisement

American Association for Cancer Research Logo Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 3, Issue 9
1 September 1997
Clinical Cancer Research Cover Image for Volume 3, Issue 9
All Issues
ISSN 1078-0432
EISSN 1557-3265
Issue Sections

Advances in Brief

Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.
T L Chenevert; P E McKeever; B D Ross
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
G K Schwartz; K Farsi; P Maslak; D P Kelsen; D Spriggs
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Research Articles

Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Y X Hu; H Watanabe; K Ohtsubo; Y Yamaguchi; A Ha; T Okai; N Sawabu
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Validation of the galactose oxidase-Schiff's reagent sequence for early detection and prognosis in human colorectal adenocarcinoma.
J H Carter; J A Deddens; J L Pullman; B M Colligan; L O Whiteley; H W Carter
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Cell therapy of a highly invasive human breast carcinoma implanted in immunodeficient (SCID) mice.
S Visonneau; A Cesano; M H Torosian; D Santoli
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
A P Kudelka; T Levy; C F Verschraegen; C L Edwards; S Piamsomboon; W Termrungruanglert; R S Freedman; A L Kaplan; D G Kieback; C A Meyers; K A Jaeckle; E Loyer; M Steger; R Mante; G Mavligit; A Killian; R A Tang; J U Gutterman; J J Kavanagh
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
P J Foxall; J M Singer; J M Hartley; G H Neild; M Lapsley; J K Nicholson; R L Souhami
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
S H Bernstein; J P Fay; N P Christiansen; L Pinero; D Shah; M Stephan; G P Herzig
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial.
C M Kurbacher; H W Bruckner; I A Cree; J A Kurbacher; L Wilhelm; G Pöch; D Indefrei; P Mallmann; P E Andreotti
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.
P Baille; R Bruno; J H Schellens; L K Webster; M Millward; J Verweij; G Montay
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
V Gandhi; E Estey; M Du; M J Keating; W Plunkett
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.
D J Macey; E J Grant; L Kasi; M G Rosenblum; H Z Zhang; R L Katz; P T Rieger; D LeBherz; M South; J W Greiner; J Schlom; D A Podoloff; J L Murray
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.
S R Chinni; R Falchetto; C Gercel-Taylor; J Shabanowitz; D F Hunt; D D Taylor
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
J Herrada; R B Iyer; E N Atkinson; N Sneige; A U Buzdar; G N Hortobagyi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.
F Shapiro; T J Yao; C Moskowitz; L Reich; D L Wuest; S Heimfeld; I K McNiece; J Gabrilove; S Nimer; M A Moore
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Angiogenic protein expression in advanced epithelial ovarian cancer.
D P Barton; A Cai; K Wendt; M Young; A Gamero; S De Cesare
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
Y Tagawa; T Yasutake; T Sawai; A Nanashima; M Jibiki; M Morinaga; F Akama; T Nakagoe; H Ayabe
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
G Dalbagni; W Han; Z F Zhang; C Cordon-Cardo; P Saigo; W R Fair; H Herr; N Kim; M A Moore
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer.
J M Hakimi; M P Schoenberg; R H Rondinelli; S Piantadosi; E R Barrack
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence.
A Fortin; M Guerry; R Guerry; M Talbot; O Parise; G Schwaab; J Bosq; J Bourhis; P Salvatori; F Janot; P Busson
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer.
B H Bochner; D Esrig; S Groshen; M Dickinson; N Weidner; P W Nichols; D G Skinner; R J Cote
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
A H Ree; V A Florenes; J P Berg; G M Maelandsmo; J M Nesland; O Fodstad
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
F J Xu; S Stack; C Boyer; K O'Briant; R Whitaker; G B Mills; Y H Yu; R C Bast, Jr
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer.
R Mazurchuk; D Glaves; D Raghavan
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.
J C Newby; S R Johnston; I E Smith; M Dowsett
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
M Gupta; S Fan; Q Zhan; K W Kohn; P M O'Connor; Y Pommier
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
B A Teicher; G Ara; D Buxton; J Leonard; R G Schaub
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.
K E McKenzie; A Siva; S Maier; I B Runnebaum; R Seshadri; S Sukumar
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Advertisement

Latest News
GLP-1 Drugs May Play Modest Role in Cancer Prevention
Improved Survival with Diet and Exercise Proven in Phase III Colon Cancer Trials
Outgunning mCRPC with SYNC-T
View more recent articles
Breaking
Pembrolizumab Boosts Event-Free Survival for HNSCC
Tafasitamab Adds Follicular Lymphoma Indication
NextCure Buys ADC for Up to $745 Million
View more recent articles
Research Watch
Central Nervous System Tumors Can Be Rapidly Molecularly Profiled during Surgery
Lipoprotein Uptake through Glycosaminoglycans Blocks Ferroptosis in Cancer
Multimodal AI Aids Specialist and General Physicians in Skin Cancer Diagnosis
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal